A 36-Week Extension to Protocol ISA04-03
Clinical trial NCT00258713 · COMPLETED
Trial details
- NCT number
- NCT00258713
- Sponsor
- Aurinia Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2006-07-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.